Cell growth regulating factor M and its prepn process

A cell growth regulation factor and gene technology, applied in the field of biomedicine, can solve the problems of abnormal repair, necrosis of human cell tissue, unsatisfactory effect, etc., and achieve the effect of TC enhancement

Inactive Publication Date: 2003-06-04
谢旭明
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are no documents with similar "longevity medicine" published.
On the other hand, even if a person has not entered old age, there will still be necrosis of human cells and tissues in some parts of his body, which cannot be repaired normally, such as patients with cervical spondylosis or patients with lumbar disc herniation, etc.
Most of these patients are elderly, and the pathogenesis is mainly due to the existence of degeneration, atrophy, and necrotic cell fibrosis in some parts of the body. The conventional treatment met

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0015] Example 2: Gram-negative cocci were first screened and the strains were frozen and preserved, and the strains were routinely cultured at a temperature of 12°C. After the strains were fully cultured, they were filtered three times successively to remove impurities and harmful bacteria, leaving beneficial bacteria fragments , which is to extract natural genes; take 1 μg of beneficial bacteria fragments, that is, natural genes, add 3 mg of glutamic acid amine quantitatively to it, measure the content, and after safety testing, seal the water under the GMP standard to form the natural cell growth regulator M , After the finished product passes the inspection, it will be printed and packaged.

Embodiment 3

[0016] Example 3, the Gram-negative bacilli were first screened and the strains were frozen and preserved, and the strains were conventionally cultured at a temperature of 20°C. After the strains were fully cultivated, they were filtered twice successively to remove impurities and harmful bacteria, leaving beneficial bacteria Fragments are the extraction of natural genes; take 1 μg of beneficial bacteria fragments, that is, natural genes, add 8 mg of glutamic acid to it quantitatively, measure the content, and after safety testing, seal the water under the GMP standard to form natural cell growth regulators M, after the finished product is inspected and passed, it will be printed and packaged.

Embodiment 4

[0017] Example 4, the Gram-positive bacilli were first screened and the strains were frozen and stored, and the strains were conventionally cultured at a temperature of 38°C. After the strains were fully cultivated, they were filtered once to remove impurities and harmful bacteria, leaving beneficial bacteria fragments. That is to extract natural genes, usually the more times of filtering, the purer the remaining (extracted) beneficial bacteria fragments, that is, the natural genes. Take 1 μg of beneficial bacteria fragments, that is, natural genes, add 20 mg of glutamic acid to it quantitatively, measure the content and pass the safety test, and seal the natural cell growth regulatory factor M under the GMP standard water agent. After the finished product passes the inspection, print Package.

[0018] Other embodiments of the present invention can be freely configured within the range of 1 μg of gene and 1 μg of configuration—500 mg of glutamic acid amine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention is natural cell regulating factor M and its preparation process. It is prepared through screening Gram-positive coccus, Gram-negative coccus or bacillus, freezing preservation of strain, conventional culture of the strain at 4-38 deg.c, filtering to filter out harmful thallus while leafing beneficial thallus or extracting natural gene, adding glutamine into the natural gene,safety inspection and forming into oral liquid or freeze dried powder. The natural cell regulating factor M product has glutamine content the same as that of natural cell regulating factor M. It has the functions of activating and strengthening immune, strengthening TC, repairing and regenerating cell tissue, vessel and liver and kidney tissue cell, etc.

Description

technical field [0001] The invention relates to a medicine beneficial to the growth regulation of biological cells and a preparation method thereof, belonging to a kind of biological medicine. Background technique [0002] Birth, old age, sickness and death are a natural law for human beings. With the aging of human cells, the regenerative function of the cells will gradually lose. The human body enters the aging period, and various cells in the human body decline. For example, the recovery of the elderly is much slower than that of the young. A lot is a good proof. Human aging is mainly manifested in cell aging and functional decline of various internal organs. Therefore, in recent years, medical experts from all over the world are trying to study "longevity medicine" to prolong human life. The so-called longevity medicine is nothing more than that this kind of medicine can promote the regeneration of human cells and the enhancement and improvement of repair ability. Howe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7088A61P11/16A61P13/12A61P37/04A61P43/00
Inventor 谢旭明谢黎升黎景黎智谢昱青朱红
Owner 谢旭明
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap